EPIC |
HLN |
Sector |
Pharma and Biotech |
ISIN |
GB00BMX86B70 |
Market Sector |
MAIN |
Market Segment |
SET1 |
Main Indices |
FTSE 100, FTSE 350, FTSE All-Share |
Country of register |
Great Britain |
Currency |
British Pound |
Market Cap |
£32,827m |
NMS |
7,500 |
Shares in issue |
8,984m |
Date Listed |
n/a |
|
Interim |
Final |
Ex-Div |
14-Aug-25 |
24-Apr-25 |
Paid |
18-Sep-25 |
05-Jun-25 |
Amount |
2.20p |
4.60p |
16:44 |
22,920 @ 365.83p |
16:44 |
37,735 @ 364.21p |
16:38 |
500,000 @ 365.68p |
16:38 |
362,752 @ 365.68p |
16:35 |
24,000 @ 365.40p |
CEO |
Brian McNamara |
CFO |
Dawn Allen |
Top of Page
You are here:
research